ArticleCureus2025
Embolization of the Middle Meningeal Artery As Primary Treatment for Chronic Subdural Hematoma in Older Filipino Adults.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic subdural hematoma (CSDH) is among the most common neurosurgical conditions in older adults, traditionally managed with burr-hole drainage, which may be associated with recurrence and perioperative risks. Embolization of the middle meningeal artery (EMMA) has recently emerged as a minimally invasive alternative with promising safety and efficacy profiles. This case series describes the institutional experience with EMMA as a primary treatment for CSDH in older Filipino adults managed in a government tertiary hospital. The majority of patients demonstrated radiographic improvement, and most showed clinical recovery without major complications. Anatomical factors, such as vessel caliber and completeness of branch embolization, appeared to influence treatment outcomes. These early findings suggest that EMMA is a feasible and potentially effective option for older adults with CSDH, particularly for those with comorbidities that increase surgical risk. Larger prospective studies are warranted to further define its role in low- and middle-income settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.